by Briana Campbell (@MsMatchGirl)
It’s a dog-eat-dog world out there, so for companies to succeed, they need to either dream big or go home. However, in a competitive world, turning a dream into reality requires action.
With social media becoming a formidable communication tool, pharma and health care companies are devising new strategies to communicate with patients, [...]
Tags:communication·digital strategy·Digital Tools·Education·engagement·Facebook·FDA·marketing·media·Pharma·Pharmaceutical industry·social media·Social network·strategy·Trends
It’s the time of year when we spend a lot of time at conferences. And we hope you enjoy our coverage.
We’re pleased to announce that we’ll be back in Philly, October 17 through 20, for the 5th annual Digital Pharma East.
Just a few things you can look forward to:
10 in depth case studies: Pfizer, Johnson [...]
Tags:communication·Communities·community·conference·Conferences·digital strategy·Education·events·Health care·healthcare·information·marketing·Pharma·Pharmaceutical industry·social media·Social network·Thought Leaders
by DJ Edgerton (@wiltonbound)
We have an interesting relationship with pharma conferences.
On the one hand, we love them. We think the chances to share best practices and nascent ideas, to learn from each other and to network are all fabulous. We’ve been to dozens, shared video and recaps, and told you about “Conferences You Should Be [...]
Tags:communication·Communities·community·conference·Conferences·Education·engagement·events·marketing·Pharma·Pharmaceutical industry·social media·Social network·strategy·Thought Leaders·Trends
by Briana Campbell (@MsMatchGirl)
Just the other day Richard Meyer posted an article entitled, “STOP! Social Media Is Not the Answer” in which he makes a strong case against pharma marketers turning to social media for their campaigns. He points out that people don’t want to connect with their drugs on social networks. He points out [...]
Tags:#hcsm·Facebook·Google·LinkedIn·marketing·Pharma·pharma marketing·Pharmaceutical industry·social·social media·Social network·social networking·Twitter
Here at Pixels & Pills, we’re always trying to push the conversation about health and pharma in the digital space harder and farther along. Which is why we were intrigued when Shwen Gee let us know about The Social Health Un-Conference (SXSH), taking place September 19th, right before ePatient Connections.
Aside from the impressive speaker list [...]
Tags:communication·Communities·community·conference·Conferences·Education·engagement·events·Health·Health care·information·innovation·Legal Issues·Patients·Pharma·Pharmaceutical industry·social media·Social network·Thought Leaders·Trends·user needs
by Briana Campbell (@MsMatchGirl)
Wrath. Sloth. Greed. Gluttony. Lust. Envy. Pride.
The seven deadly sins.
In June of this year, PM360 laid out the Seven Deadly Sins of Pharma Marketing (you can take a peek at the digital edition here). And Dave Sonderman laid out his accompanying thoughts on the unintentional sins in a post on the GSW [...]
Tags:#hcmktg·#hcsm·communication·Communities·community·digital strategy·Digital Tools·Education·Facebook·FDA·Health·Health care·healthcare·information·marketing·Pharmaceutical industry·social media·social media platforms·social media strategies·Social network·strategy·Trends·Twitter
by Briana Campbell (@MsMatchGirl)
About a week and a half ago all the talk was about Facebook and its policy changes, disallowing pharmaceutical companies to turn off comments on their walls. Jonathan Richman ran a deathwatch over on Dose of Digital. The Washington Post had a story. We wrote about it, too. Seems like everyone did. [...]
Tags:communication·Communities·community·Facebook·FDA·FDA Guidance·John Mack·Jonathan Richman·NPR·Online community·Pharma·Pharma industry·Pharmaceutical industry·Pharmaguy·social media·Social network·social networks·user needs
by Briana Campbell (@MsMatchGirl)
The talk, for a long while now, has been about Facebook’s change of guidelines, no longer allowing pharmaceutical companies to turn off comments on their Facebook walls. Yesterday, D-Day arrived.
Over on Dose of Digital, Jonathan Richman, was keeping a “deathwatch” vigil over pages that were apt to be removed. On Friday, the [...]
Tags:communication·Communities·community·digital strategy·Digital Tools·engagement·Facebook·FDA·information·innovation·Legal Issues·Pharma·Pharmaceutical industry·social media·Social network·technology
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
by DJ Edgerton (@wiltonbound)
Some very [...]
Tags:Compliance·Digital Tools·Education·Health·Health care·information·Patients·Pharma·Pharmaceutical industry·social media·Social network·Trends·user needs
by Briana Campbell (@MsMatchGirl)
A recent Pew Internet study, released June 16, 2011, shared the following statistic: Facebook users are overall more trusting than non-internet others. 43% of [study] participants were more likely than other internet users to feel that most people can be trusted.” With 51% of the American population over 12 years old on [...]
Tags:Communities·community·digital strategy·Education·Facebook·information·patient·Patients·Pharma·social media·Social network·user needs
